Fexofenadine Hydrochloride
NDC 73581-025, Fexofenadine Hydrochloride, tablet, from YYBA Corp.
- Product NDC
- 73581-025
- Status
- Listed
- Labeler
- YYBA Corp
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA211075
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73581-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73581-025-01 | 73581002501 | 10 TABLET in 1 BOTTLE (73581-025-01) |
| 73581-025-06 | 73581002506 | 60 TABLET in 1 BOTTLE (73581-025-06) |
| 73581-025-20 | 73581002520 | 200 TABLET in 1 BOTTLE (73581-025-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 73581-025 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73581-025 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73581-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.